Finnrick, an independent testing programme, publishes 30 assays for Alpha-Gen: 13 met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation) and 17 did not. Most recent assay 21 May 2025.
Alpha-Gen listed by Finnrick as "Trading". Source: Finnrick, https://www.finnrick.com/vendors/alpha-gen.
Alpha-Gen sells to businesses rather than direct to researchers. It lists 23 products.
In its own words: “Alpha Generation manages and operates power generation facilities that are well positioned to provide reliable, secure, safe, and sustainable sources of power and meet the growing infrastructure needs created by electrification. This diverse portfolio of assets is owned by funds managed by ArcLight Capital Partners, LLC, a leading middle-market, value added infrastructure investment firm with strategic partnerships a”
We found no test results or certificates anywhere on Alpha-Gen's site.
No prices are published. You have to ask before you can compare cost against another supplier.
Worth knowing before you order: no published COAs and no research-use-only notice. We found no certificates of analysis or third-party test results anywhere on the site.
Site check: 23 products listed.
Alpha-Gen is listed as active. Finnrick Grade D. Finnrick avg score: 6/10 across 30 samples (6 products). Below-average quality. Exercise caution.
Alpha-Gen holds independent lab grade D, assigned across 30 graded samples, average score 6/10. That grade comes from an independent grader's own sampling, not from PeptideAtlas, and it describes the samples that grader obtained rather than every batch sold.
| Product | Assays | Result |
|---|---|---|
| BPC-157 | 5 | 2 passed, 3 failed |
| CJC-1295 | 5 | 0 passed, 5 failed |
| Ipamorelin | 5 | 2 passed, 3 failed |
| Retatrutide | 5 | 4 passed, 1 failed |
| Semaglutide | 5 | 3 passed, 2 failed |
| Tirzepatide | 5 | 2 passed, 3 failed |
Source: Finnrick, as published 2026-08-09. Pass and fail are Finnrick's classification against its own threshold, not ours.
| Status | Active |
|---|---|
| Independent lab grade | D (30 samples) |
| Average grader score | 6/10 |
| Vendor type | Research-use supplier |
These details were read from Alpha-Gen's own website on 2026-08-10. Pages consulted:
Alpha-Gen is listed as active and we hold 30 Finnrick assays (13 passing, 17 failing its purity threshold); an independent lab grade of D. That is evidence about the batches that were tested or published, not a guarantee about the vial you receive.
Yes. Finnrick, an independent testing programme, publishes 30 assays for Alpha-Gen: 13 met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation) and 17 did not. Most recent assay 21 May 2025.
Similar vendors: SwissChems, Bfflink, Reta-Peptide, HkRoids, Zenith Jove Peptide ZJ, Shanghai Baoju, Heman Peptide HM, Allen Biotechnology Co ABC.
Popular peptides: Semaglutide, Tirzepatide, Retatrutide, BPC-157, CJC-1295, Ipamorelin.
Other reviewed vendors: Alpha Grade Peptides Review, Alpha Omega Peptide Review, Altherapy Miami Peptides Review.